New Antibody-Based Drug is a ‘Great Stride’ Forward to Improving Outcomes in Non-Hodgkin and Hodgkin Lymphoma

New Antibody-Based Drug is a ‘Great Stride’ Forward to Improving Outcomes in Non-Hodgkin and Hodgkin Lymphoma

×
NOW
PLAYING
“My Chemo Smirk!” Radio Host Dan Bongino Shares Treatment Picture As He Fights Hodgkin Lymphoma
NOW
PLAYING
What to Know About Diet and Exercise if You Have Cancer
NOW
PLAYING
Exciting New Options Are Available for Lymphoma Recurrence
NOW
PLAYING
The Promise - and Risks - of CAR T-Cell Therapy
NOW
PLAYING
Imbruvica Treats Relapsed Lymphoma in a Different Way
NOW
PLAYING
Bispecific Antibodies -- the Future of Non-Hodgkin Lymphoma Treatment

SurvivorNetTV.
Hope. Science.
Inspiration.

Discover SNTV

Treatment : Understanding the Options for Diffuse Large B-Cell Lymphoma

SEE MORE   

  • The treatment you get for non-Hodgkin lymphoma will depend on the type of lymphoma, the stage and the how fast it’s growing
  • Diffuse large B-cell lymphoma is the most common type diagnosed in the United States and worldwide
  • People with aggressive non-Hodgkin lymphoma can expect to get a chemotherapy combination called R-CHOP

Treatment : Understanding the Options for Diffuse Large B-Cell Lymphoma

  • The treatment you get for non-Hodgkin lymphoma will depend on the type of lymphoma, the stage and the how fast it’s growing
  • Diffuse large B-cell lymphoma is the most common type diagnosed in the United States and worldwide
  • People with aggressive non-Hodgkin lymphoma can expect to get a chemotherapy combination called R-CHOP

Treatment : Chemotherapy

SEE MORE   

Treatment : Treating Non-Hodgkin Lymphoma in Children

SEE MORE   

Treatment : Treating Non-Hodgkin Lymphoma in Children

  • Children with non-Hodgkin lymphoma are typically given more aggressive chemotherapy because their bodies are generally able to tolerate it better
  • Long-term survival in children with B-cell non-Hodgkin lymphoma is over 90%

Treatment : Mantle Cell Lymphoma

SEE MORE   

  • Mantle cell lymphoma is a type of non-Hodgkin lymphoma
  • The disease can be either slow-growing (indolent) or fast-growing (aggressive)
  • Aggressive mantle cell lymphoma may be treated with a combination of a monoclonal antibody (rituximab) and chemotherapy

Treatment : Mantle Cell Lymphoma

  • Mantle cell lymphoma is a type of non-Hodgkin lymphoma
  • The disease can be either slow-growing (indolent) or fast-growing (aggressive)
  • Aggressive mantle cell lymphoma may be treated with a combination of a monoclonal antibody (rituximab) and chemotherapy
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.